Topics

Companies Related to "Amneal licences myasthenia gravis drug from Kashiv BioSciences" [Most Relevant Company Matches] RSS

15:51 EDT 3rd April 2020 | BioPortfolio

Here are the most relevant search results for "Amneal licences myasthenia gravis drug from Kashiv BioSciences" found in our extensive corporate database of over 50,000 company records.

Showing "Amneal licences myasthenia gravis drug from Kashiv BioSciences" Companies 1–25 of 4,000+

Extremely Relevant

Amneal Pharmaceuticals LLC

Amneal Pharmaceuticals LLC is a U.S.-based manufacturer of generic pharmaceuticals. Known as “Generic’s New Generation”, Amneal prides itself on its unwavering commitment to quality, meaningful business relationships, and innovative approach to maximizing value for all stakeholders. Extensive investment in R&D, an intelligently aggressive ex...


Amneal Pharmaceuticals Pty Ltd

Amneal Pharmaceuticals LLC is a global supplier of generic pharmaceuticals, vertically-integrated across the entire supply chain from R&D to finished goods. Since its inception in 2002, Amneal has invested extensively in R&D resources, manufacturing infrastructure, and strategic expansion opportunities—all contributing to its significant growth. The C...

Relevant

Amneal Pharmaceuticals, LLC

Amneal Pharmaceuticals, LLC, with principal offices in Bridgewater, NJ, is a U.S.-based firm that develops, manufactures and distributes generic pharmaceuticals regulated and approved by the U.S. FDA. Known as “Generic’s New Generation,” the company utilizes its newly expanded R&D and manufacturing capabilities to conceive breakthrough developments...


Ester Neurosciences Ltd

Ester Neurosciences Ltd. is a development stage biopharmaceutical company committed to the discovery and development of novel therapeutic products for the treatment of neurological disorders such as myasthenia gravis, Alzheimer's disease, multiple sclerosis and acute stress reactions. Ester's unique platform technology is based on the company's breakthrough discoveries relating to cholinergic neur...

Asana BioSciences, LLC

Asana BioSciences, LLC, an independent member of the Amneal Alliance of Companies, is a research and development company based in Bridgewater, NJ specializing in the discovery and development of new chemical and biological entities. Asana’s portfolio consists of multiple early-stage drug discovery and development candidates in a variety of therapeutic ...

Kashiv Pharma, LLC

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using its expertise in novel ion channels. Hydra Biosciences’ proprietary platforms enable the company to identify and develop drug candidates that address significant unmet medic...

Carna Biosciences Inc.

Carna Biosciences is a biotechnology venture company established in April, 2003 as a spin-off of a R&D laboratories.Mission Conducting drug discovery programs with a focus on cellular signaling as well as providing drug discovery supporting services to pharmaceutical companies with our proprietary technologies.

Amneal Enterprises, LLC

Amneal Enterprises, LLC, with principal offices in Bridgewater, NJ, is a U.S.-based alliance of independent, diverse, closely-held life science companies with products ranging from generic drugs to specialty pharma and biologicals to innovative delivery technologies. While all member enterprises and management teams are independent and unique to their busi...

Carna Biosciences, Inc.

Carna Biosciences, Inc. (www.carnabio.com), founded in April 2003, is a Japanese biotechnology company conducting intercellular signaling-based drug discovery programs, as well as providing drug discovery services to pharmaceutical companies, using proprietary technologies in gene cloning, active kinase protein expression, protein purification and homogeneous assay development.

Neuro-Hitech

Neuro-Hitech is focused specifically on the development and commercialization of next-generation therapies against proven targets for neurodegenerative diseases. The company’s signature offering, Huperzine A is being tested for efficacy in the treatment of Alzheimer's disease and the company has plans to study other degenerative disorders such as vascular dementia, mild cognitive impairment and ...

Ensysce Biosciences, Inc.

Ensysce Biosciences, San Diego, CA, is an integrated drug delivery company for both small and large molecules. To overcome the major problem of non-medical use of opioid products, Ensysce is using its prodrug technology to improve abuse deterrent properties. The BIO-MD™ prodrug abuse deterrent and MPAR™ overdose resistant pain platforms, with wor...

ACLARA Biosciences Incorporated

ACLARA BioSciences develops microfluidics array technologies, often referred to as "lab-on-a-chip" systems. Our proprietary technology targets genomic applications--RNA and DNA analysis--and high-throughput pharmaceutical drug screening.

Fluxion Biosciences

Fluxion Biosciences provides cellular analysis tools for use in critical life science research and drug discovery applications. Fluxion’s proprietary microfluidic platform enables precise functional analysis of individual cells in a multiplexed format. Fluxion’s systems meet the rigorous demands of life science and drug discovery scientists by pr...

Luxcel Biosciences Ltd.

The mission of Luxcel Biosciences is to become a leading provider of new enabling R&D tools and solutions to the research community, particularly for drug discovery, biomedical, environmental and food sectors. This is achieved by developing and commercializing a spectrum of proprietary platform technologies.

DARA BioSciences, Inc.

DARA BioSciences, Inc. is a Raleigh, North Carolina based development-stage biopharmaceutical company that acquires promising therapeutic small molecules and develops them through proof of concept in humans for subsequent sale or out-licensing to larger pharmaceutical companies. Presently DARA has two drug candidates with cleared IND’s (Investigationa...

LegoChem Biosciences, Inc.

LegoChem Biosciences is a biopharmaceutical company focusing on the development of next-generation novel therapeutics utilizing its proprietary medicinal drug discovery technology LegoChemistry™ & ADC platform technology ConjuAll™. Since its foundation in 2006, LCB has focused on the research and development of ADC (Antibody-Drug-Conjugates), ant...

Fluxion Biosciences, Inc.

Fluxion Biosciences provides cellular analysis tools for use in critical life science research and drug discovery applications. Fluxion’s proprietary microfluidic platform enables precise functional analysis of individual cells in a multiplexed format. Products include the BioFlux™ system for studying cellular interactions and the IonFlux™ system f...

Ricerca Biosciences, LLC

Ricerca Biosciences offers a comprehensive suite of discovery and preclinical services to support drug candidates from discovery through IND on a global scale, including capabilities in discovery and medicinal chemistry, API process chemistry, cGMP manufacturing and scale-up, IND-enabling toxicology, molecular profiling, pharmacology/DMPK and drug s...

PIramed Limited

PIramed was founded by Professor Michael Waterfield FRS (Ludwig Institute for Cancer Research, London), Professor Peter Parker (Cancer Research UK) and Professor Paul Workman (Institute of Cancer Research, London). To date, the Company has received £10m in equity and convertible loans from JPMorgan Partners and Merlin Biosciences.Principal intellectual property licences are to PI 3-kinase p110a (...

Carmel Biosciences

Carmel Biosciences, based in Atlanta, Georgia is focused on clinical research and small molecule discovery and development in the areas of prescription drugs and nutraceuticals which are based on the synthetic combination of two known drug entities to mitigate risk factors in cardiovascular, metabolic and central nervous system diseases.

Presage Biosciences

Presage Biosciences is an oncology company pioneering the incorporation of human efficacy data much earlier in the drug development and clinical trial processes with its patented CIVO arrayed microinjection platform. The CIVO platform allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a ...

Abreos Biosciences

Abreos Biosciences is focused on ligand binding assays for biologic and biosimilar drug development, activity validation, authentication, and precision dosing, as well as massively multiplexed biomarker assays. Abreos has already developed reagents for the detection of several drugs currently available on the market such as rituximab, obinutuzumab, trastuz...

AVIVA Biosciences Corporation

AVIVA Biosciences CorpBased in San Diego, CA., AVIVA Biosciences Corporation develops enabling drug discovery and development technologies by combining biochips with cell biology. Key application areas include electrophysiology research, ion channel drug screening and rare-cell isolation. Founded in 1999 the company has addressed the unmet needs of pharmaceutical and biotechnology industries by in...

CXR Biosciences Ltd

CXR Biosciences is committed to accelerating drug development, reducing late stage product attrition, and accurately determining the drug safety characteristics of chemicals.We specialise in :Developing novel models for drug metabolism and toxicological screening that are more rapid, more informative and more relevant to man. using conventional and state of the art technologies to provide accurate...


More From BioPortfolio on "Amneal licences myasthenia gravis drug from Kashiv BioSciences"

Quick Search

Corporate Database Quicklinks